Psilocybin and Serotonin: The Neuroscience Explained Simply
Psilocybin works primarily through 5-HT2A serotonin receptors — but its effects are far more complex than simply 'increasing serotonin.' Here's the neuroscience explained clearly.
Psilocybin is often described as "working on serotonin" — but this description is incomplete and potentially misleading. Here's what actually happens in the brain.
Psilocybin → Psilocin
Psilocybin itself is not the active compound. When you consume psilocybin, it is rapidly converted to psilocin by alkaline phosphatases in the body. Psilocin is the compound that crosses the blood-brain barrier and produces psychedelic effects.
The 5-HT2A Receptor
Psilocin's primary mechanism of action is as a partial agonist at 5-HT2A serotonin receptors — meaning it binds to and activates these receptors, but with less efficacy than the natural ligand (serotonin).
5-HT2A receptors are found throughout the brain, but are particularly concentrated in:
Why 5-HT2A Activation Produces Psychedelic Effects
The thalamus acts as a "gatekeeper" — it filters sensory information before it reaches the cortex. 5-HT2A activation in the thalamus reduces this filtering, allowing more sensory information to reach conscious awareness. This is one mechanism behind the perceptual enhancement and visual effects.
In the prefrontal cortex and default mode network, 5-HT2A activation disrupts the normal patterns of neural activity — reducing the rigid, repetitive patterns that characterize depression, anxiety, and addiction.
Psilocybin Is Not an SSRI
SSRIs (selective serotonin reuptake inhibitors) work by blocking the reuptake of serotonin from synapses, increasing serotonin availability. This is a fundamentally different mechanism from psilocybin.
Psilocybin does not increase serotonin levels. It activates specific serotonin receptors (primarily 5-HT2A) in a way that produces acute disruption of neural patterns, followed by neuroplasticity and lasting changes in brain connectivity.
The Neuroplasticity Mechanism
The 5-HT2A activation by psilocybin triggers a cascade that ultimately leads to:
These changes persist long after psilocin has been cleared from the body — which is why a single psilocybin session can produce lasting therapeutic effects.
Why SSRIs Blunt Psilocybin Effects
SSRIs downregulate 5-HT2A receptors over time (as a compensatory response to increased serotonin). Since psilocybin works through 5-HT2A receptors, SSRIs reduce psilocybin's effectiveness. This is why clinical trials typically require participants to taper off SSRIs before psilocybin sessions.
This article is for informational purposes only and does not constitute medical advice.
This article is for informational purposes only and does not constitute medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before making any changes to your health regimen.